Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with Terumo. The agreement relates to the New Hope, Pennsylvania-based company’s Virtue Sirolimus AngioInfusion Balloon (SAB). It supersedes and terminates a prior distribution agreement between the companies and grants Terumo a right of first refusal (ROFR) to acquire […]
Funding Roundup
Vivani prices $15.7M offering
Vivani Medical (Nasdaq:VANI) announced that it priced a best efforts registered direct offering of 6 million shares of common stock. The Alameda, California-based company priced the shares at $1.62 apiece. It also announced a concurrent private placement of more than 3.7 million shares of common stock at the same price. Gregg Williams, the company’s board […]
ViCentra closes upsized $85M Series D round to support next-gen automated insulin patch pump
ViCentra announced today that it closed an upsized Series D financing round worth proceeds of $85 million. New investor Innovation Industries led the round with matching participation from existing investors Partners in Equity and Invest-NL. EQT Life Sciences and Health Innovations also provided its continued support in the round. Utrecht, The Netherlands-based ViCentra plans to […]
Vaxxas raises $58.4M for needle-free vaccine delivery tech, announces CEO change
Vaxxas announced today that it raised $58.4 million (A$90 million) in a new financing round supporting its vaccine delivery technology. The Brisbane, Australia-based company picked up about $32 million in new Series D equity and about $26 million in debt facilities. It also has additional commitments under discussion as it continues to attract investor interest. […]
Twin Health raises $53M for digital twin tech for diabetes, weight loss
AI digital twin developer Twin Health announced that it brought in a $53 million investment round, led by Maj Invest of Denmark. Mountain View, California-based Twin Health says the funds can help accelerate its expansion. It hopes to widen its reach among health plans and clients in retail, healthcare, financial services, technology and manufacturing. This […]
Luna Diabetes raises $23.6M Series A for automated insulin patch pump
Luna Diabetes announced today that it closed a $23.6 million Series A financing round to support its insulin delivery technology. Vensana Capital led the financing round for the San Diego-based company. The Swiss Diabetes Venture Fund, Ascensia Diabetes Care, Winklevoss Capital and other prominent investors also participated. Funding supports the development of Luna, the company’s […]
Vivani closes $10M financing, advances GLP-1 implant
Vivani Medical (Nasdaq:VANI) announced that it brought in $10 million in equity financing as it progresses its drug delivery technology. Alameda, California-based Vivani develops NanoPortal technology, which steadily delivers medication over extended periods of time. The company aims to guarantee correct patient doses while avoiding potential safety concerns around fluctuating drug release profiles. It can also […]
MannKind submits inhaled insulin to FDA for pediatrics, inks $500M financing agreement with Blackstone
MannKind (Nasdaq:MNKD) today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said. First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin […]
Sava raises $19M to advance glucose biosensor
Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor technology. Balderton Capital and Pentland Ventures led the round, with new investors Norrsken VC and JamJar Investments joining, too. Other investors included True, Italian Founders Fund, Athletico Ventures, SOLO Investments and Exceptional Ventures. The funding […]
Drug delivery tech developer Stevanato Group brings in $235.5M financing
Stevanato Group today announced that it secured $235.5 million (€200 million) in financing to support ongoing capital expenditure projects. The Piombino Dese, Italy-based drug delivery device developer plans to use funds to support projects in Cisterna di Latina (Italy) and Fishers, Indiana. It picked up the funds through agreements with BNL BNP Paribas, Cassa Depositi […]
